Brevan Howard Capital Management LP Guardant Health, Inc. Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 11,757 shares of GH stock, worth $533,532. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,757Holding current value
$533,532% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GH
# of Institutions
336Shares Held
124MCall Options Held
843KPut Options Held
2.25M-
Vanguard Group Inc Valley Forge, PA12.1MShares$547 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$510 Million0.01% of portfolio
-
Cadian Capital Management, LP New York, NY6.93MShares$315 Million8.13% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$272 Million5.07% of portfolio
-
Baillie Gifford & CO5.45MShares$247 Million0.13% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.64B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...